The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


TEVETEN 400 mg, film-coated tablets



Mylan IRE Healthcare LimitedPA2010/017/001

Main Information

Trade NameTEVETEN 400 mg, film-coated tablets
Active SubstancesEprosartan mesylate
Dosage FormFilm-coated tablet
Licence HolderMylan IRE Healthcare Limited
Licence NumberPA2010/017/001

Group Information

ATC CodeC09CA Angiotensin II antagonists, plain
C09CA02 eprosartan

Status

License statusAuthorised
Licence Issued05/09/1997
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back